PharmAthene IncAdd to My Watchlist

PIP:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 1.68
  • 0.06  3.70%
    Today's Change
  • 1.62
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 2/27/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding63 million
Market Cap$106 million
Return on Equity ttm-79.78%
Last DividendPIP:US does not pay a dividend
EPS: Year Actual ttm-0.174
EPS: Year Est. 12/14 ttm--
EPS: Quarterly Actual 9/14 -0.08
EPS: Quarterly Est. 12/14 --
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-130.00
Company Description
PharmAthene, Inc. develops biological and chemical defense products. The Company's services include expertise in infectious diseases and genome science across the spectrum to pharmaceutical marketing and management.
Revenue$18 million
Net Income$-12 million
Total Assets$17 million

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!